Laparoscopic Gynecologic Surgery With Robotic Assistance System Kymerax® : Pilot Study
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01953627|
Recruitment Status : Unknown
Verified July 2014 by Assistance Publique Hopitaux De Marseille.
Recruitment status was: Recruiting
First Posted : October 1, 2013
Last Update Posted : July 24, 2014
Laparoscopic robotic surgery (LSM) seems to increase quality of surgery. Diffusion of LSM is limited by cots of the only available system today. Kymerax® is a cheaper new system of LSM.
Aim : To evaluate feasibility of laparoscopy with Kymerax® system in different laparoscopic procedures in gynecology.
Material and methods : Observational study. Inclusion criteria were : patient requiring laparoscopic procedure in gynecology who give informed consent. The investigators evaluate procedures routinely performed by laparoscopy in gynecology.
Hypothesis : Procedures performed routinely in gynecology were feasible with Kymerax® system.
|Condition or disease||Intervention/treatment||Phase|
|Gynecological Surgery||Procedure: Surgical procedure with the system Kymerax Device: The system Kymerax||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||150 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Laparoscopic Gynecologic Surgery With Robotic Assistance System Kymerax® : Pilot Study|
|Study Start Date :||October 2012|
|Estimated Primary Completion Date :||September 2014|
|Estimated Study Completion Date :||December 2014|
|Experimental: Surgical procedure with the system Kymerax||
Procedure: Surgical procedure with the system Kymerax
Device: The system Kymerax
- assessment of Kymerax systemerax [ Time Frame: 18 months ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01953627
|Contact: aubert AGOSTINIfirstname.lastname@example.org|
|Assistance Publique Hopitaux de Marseille||Recruiting|
|Marseille, France, 13354|
|Contact: AUBERT AGOSTINI email@example.com|
|Study Director:||BERNARD BELAIGUES||Assistance Publique Hopitaux De Marseille|
|Principal Investigator:||aubert AGOSTINI||AP HM|